Long-lived immune cells show promise against cancer in world-first trial

Conventional CAR T cells (purple and yellow spheres; artificially coloured) attack a cancer cell. Credit: Steve Gschmeissner/Science Photo Library The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that they could be more potent and less toxic than the standard mix of cells used in therapies for cancer . …